What is Concierge Medicine?
Concierge medicine — also called retainer medicine, boutique medicine, membership medicine, or direct primary care — is a healthcare delivery model in which patients pay a recurring annual, quarterly, or monthly membership fee directly to a physician or practice in exchange for enhanced, highly personalized access to care. In a traditional fee-for-service system, a primary care physician might manage a panel of 2,000 to 2,500 patients, rush through 20 to 25 appointments a day, and spend an average of just 15 to 20 minutes per visit. Concierge medicine flips that model entirely. Physicians cap their panels at 300 to 600 patients, see 6 to 10 people per day, and routinely spend 30 minutes to an hour or more per visit — building the kind of ongoing, deeply personalized clinical relationship that modern healthcare has largely forgotten how to deliver. By 2026, what started as an exclusive niche for the ultra-wealthy has evolved into one of the fastest-growing segments of American healthcare, attracting physicians fleeing burnout, patients fed up with assembly-line medicine, and corporations offering it as a premium employee benefit. Major health systems including Cleveland Clinic, Johns Hopkins, Northwestern Medicine, Massachusetts General Hospital, and Rush University now operate concierge medicine programs — a signal that this is no longer a fringe offering, but a structural shift in how Americans access care.
The backdrop against which concierge medicine in the US in 2026 is growing so aggressively is a healthcare system under genuine strain from multiple directions simultaneously. The Association of American Medical Colleges (AAMC) projects a shortage of up to 86,000 physicians by 2036, including up to 40,400 primary care physicians — the very doctors who would otherwise serve as most Americans’ first point of contact. The average wait time for a new primary care appointment across major US cities has reached 31 days in 2025, with some markets stretching to 27 to 70 days. More than 7 in 10 Americans say the healthcare system has major problems or is in crisis, and for the first time in Gallup’s two-decade polling history, more than half of Americans rated US healthcare quality as subpar. Into this environment of systemic failure, concierge medicine and precision diagnostics in 2026 are offering a different proposition entirely: fewer patients, more time, proactive prevention, same-day access, and care that actually knows your name.
Interesting Key Facts About Concierge Medicine in 2026
| Fact | Detail |
|---|---|
| Global concierge medicine market (2026) | Estimated at $24.63 billion in 2026, growing to $37.98 billion by 2031 |
| US concierge medicine market (2025) | Valued at $7.35–$8.09 billion in 2025 (US segment) |
| Global market CAGR (2026–2031) | 9.05% compound annual growth rate |
| US concierge practices growth (2018–2023) | Number of US concierge practices grew by 83.1% between 2018 and 2023 |
| Affiliated clinicians growth (2018–2023) | Affiliated clinicians climbed 78.4% in the same period |
| Traditional PCP patient panel | Traditional PCPs manage 2,000–2,500 patients; see 20–25 per day |
| Concierge physician patient panel | Concierge doctors limit panels to 300–600 patients; see 6–10 per day |
| Daily patient volume reduction | Concierge doctors see 80–90% fewer patients than traditional practice counterparts |
| MDVIP physician satisfaction (2024) | 96% physician satisfaction and 90% patient retention reported in December 2024 |
| US physician burnout rate (2025) | ~47% of physicians reported at least one burnout symptom in 2025 (Medscape) |
| Annual membership fee range (US) | $1,500 to $30,000 per year depending on practice tier and service level |
| Average wait for primary care (US, 2025) | 31 days average wait for a new PCP appointment (2025 Survey of Physician Appointment Wait Times) |
| Physician shortage projected (AAMC, 2036) | Up to 86,000 physicians short by 2036, including 20,200–40,400 primary care physicians |
| 76 million Americans | Live in primary care deserts (HRSA) |
| Precision medicine market (2026) | Global precision medicine market projected at $138.67 billion in 2026, growing at 16.26% CAGR |
| Employer corporate adoption | Corporate benefits groups embed concierge memberships for roughly 5 million covered employees |
Source: Mordor Intelligence Concierge Medicine Market Report, January 2026; Grand View Research US Concierge Medicine Report 2024; AAMC Physician Supply and Demand Projections 2024; 2025 Survey of Physician Appointment Wait Times; HRSA Primary Care Workforce Data; Medscape National Physician Burnout Report 2025; Precedence Research Precision Medicine Market 2025
The numbers above tell a story that is simultaneously about a booming industry and a broken healthcare system. The 83.1% surge in concierge practices between 2018 and 2023 is not a marketing trend — it is a direct response to unsustainable conditions in traditional medicine. Physicians dealing with 2,000+ patient panels, 15-minute appointments, and administrative overload are converting to models that let them practice real medicine again. The 96% physician satisfaction and 90% patient retention at MDVIP are remarkable numbers in any professional context, and they suggest that when medicine is given the time and structure it needs to work properly, both the doctor and patient experience transforms completely.
The precision diagnostics facts embedded in this picture are equally striking. The global precision medicine market hitting $138.67 billion in 2026 — growing at a staggering 16.26% CAGR — reflects the technological infrastructure that makes personalized medicine possible at scale: genomic sequencing, AI-powered diagnostic tools, companion diagnostics, biomarker testing, and pharmacogenomics. Concierge medicine and precision diagnostics are not separate trends — they are the demand and supply sides of the same shift in healthcare philosophy. One creates the time and relationship depth needed to deploy personalized clinical data meaningfully; the other generates the data that makes those clinical decisions precise. Together, they represent the future architecture of American healthcare for anyone who can access it.
Concierge Medicine Market Size & Growth Statistics in the US 2026
| Market Segment | 2025 Value | 2026 Value | CAGR | Future Projection |
|---|---|---|---|---|
| Global concierge medicine (Research & Markets) | $22.59 billion | $25.05 billion | 10.9% | $36.41 billion by 2030 |
| Global concierge medicine (Mordor Intelligence) | — | $24.63 billion | 9.05% | $37.98 billion by 2031 |
| Global concierge medicine (Precedence Research) | $21.77 billion | $23.23 billion | 6.70% | $39.02 billion by 2034 |
| Global concierge medicine (Toward Healthcare) | $20.51 billion | $22.26 billion | 8.55% | $46.59 billion by 2035 |
| US concierge medicine (Grand View Research) | $8.09 billion | — | 10.33% | $13.23 billion by 2030 |
| US concierge medicine (Precedence Research) | $6.55 billion | $6.99 billion | 6.88% | $11.97 billion by 2034 |
| North America global market share | 38–43% | Dominant | — | Retains leadership through forecast period |
| Group ownership share (2025) | 59.83–64.2% of global market | — | — | Group model remains dominant |
| Primary care application share (2025) | 26.72–38.6% of market | — | — | Largest single application segment |
| Virtual-only concierge platforms CAGR | — | — | 13.32% | Fastest-growing delivery mode through 2031 |
| Pediatrics segment CAGR | — | — | 11.62% | Highest-growth application category |
| Mid-tier membership revenue share | 39.28% of market (2025) | — | — | $3,000–$10,000/year tier |
Source: Research and Markets Concierge Medicine Report 2026; Mordor Intelligence Concierge Medicine Market January 2026; Precedence Research Concierge Medicine Market July 2025; Grand View Research US Concierge Medicine Report 2024; Toward Healthcare Concierge Medicine Report December 2025; Coherent Market Insights 2025
The concierge medicine market in 2026 is not one story but several overlapping ones, and the spread across market research estimates — from $22.26 billion to $25.05 billion globally — reflects genuine variations in what each firm includes in scope rather than analytical disagreement about growth direction. Every credible source agrees on one thing: this market is accelerating. The 10.9% CAGR cited by Research and Markets for the 2025–2026 transition alone is extraordinary for a healthcare sector, and even the more conservative 6.70% estimate from Precedence Research represents sustained above-average healthcare growth in an era of flat or declining reimbursements in traditional practice.
What is particularly notable in the 2026 segmentation data is where the growth is coming from. Virtual-only concierge platforms growing at 13.32% CAGR — the fastest delivery mode — signal that concierge medicine is no longer exclusively a luxury of urban geography. A physician in a remote state can now serve a concierge panel using remote monitoring devices, telehealth platforms, and annual in-person visits, extending premium care access beyond the zip codes that have historically defined it. Pediatrics growing at 11.62% CAGR reflects affluent parents investing in proactive health management for their children — a demographic behavior that mirrors what drove growth in adult concierge medicine a decade earlier. The group ownership model commanding 59–64% of the global market represents the institutional maturation of what started as solo physicians quietly shrinking their panels.
US Primary Care Crisis Driving Concierge Medicine in 2026
| Healthcare System Metric | Statistic |
|---|---|
| Average wait for new PCP appointment (US) | 31 days nationwide average |
| Wait times in major US cities | 27 to 70 days depending on market |
| Projected physician shortage by 2036 (AAMC) | Up to 86,000 physicians |
| Projected primary care physician shortage (2036) | Between 20,200 and 40,400 primary care physicians |
| Americans living in primary care deserts | 76 million |
| Physicians considering leaving practice within 5 years | 2 in 5 (40%) |
| Physicians aged 65+ (approaching retirement) | More than 1 in 5 (20%) |
| Physicians aged 55–64 | Another 22% approaching retirement |
| Physicians not accepting new patients | Majority of PCPs cannot take new patients |
| US physician burnout rate (2025) | ~47% reported at least one burnout symptom |
| Burnout rate (2024, AMA survey) | 43% of US physicians reported burnout |
| Traditional PCP patients managed | 2,000–2,500 patients per physician |
| Medicare reimbursement decline | 29% downward slide over the last two decades |
| Americans rating healthcare as subpar | More than half — a new high; 31% “only fair,” 21% “poor” |
| Chronic diseases share of US healthcare spending | 90% of the nation’s $3.8 trillion annual healthcare expenditures (CDC) |
Source: AAMC Physician Supply and Demand Projections March 2024; HRSA Workforce Data; 2025 Survey of Physician Appointment Wait Times; Medscape National Physician Burnout Report 2025; AMA Physician Burnout Survey 2024; Society for Women’s Health Research August 2025; Gallup Annual Healthcare Poll; CDC Chronic Disease Data
The primary care crisis driving concierge medicine adoption in 2026 is not a future problem — it’s a present emergency. A 31-day national average wait for a primary care appointment means that when a patient develops a new symptom, they will wait a full month before seeing a doctor, during which time a manageable condition can escalate into an urgent one. In major US cities the wait stretches to 70 days — over two months — for new patients. Against this backdrop, the concierge medicine promise of same-day or next-day appointments, 24/7 physician access, and 30–60 minute consultations isn’t luxury, it’s basic functionality that the standard system can no longer provide.
The physician workforce data amplifies the urgency considerably. With 20% of US physicians already 65 or older, another 22% between 55 and 64, and 2 in 5 physicians contemplating leaving practice within five years, the supply side of the equation is moving in exactly the wrong direction at exactly the wrong time. The AAMC’s projection of up to 86,000 physicians short by 2036 — built from the very conservative assumption that current residency slot growth continues — almost certainly understates the actual gap if burnout-driven early retirements accelerate. The 47% burnout rate in 2025 and 29% real-terms decline in Medicare reimbursements over two decades create a physician workforce that is simultaneously overworked, underpaid by specialty comparison, and increasingly unwilling to continue in traditional models. Concierge medicine, for many physicians, is not a luxury choice — it is a survival strategy.
Concierge Medicine Physician & Practice Statistics in the US 2026
| Physician / Practice Metric | Statistic |
|---|---|
| Estimated US concierge medicine physicians | Between 7,000 and 22,000 US physicians participate |
| Retainer physicians in the US (2019 estimate) | 5,000 to 20,000 retainer physicians |
| US concierge practice growth (2018–2023) | Grew by 83.1% — from niche to major market signal |
| NP/PA workforce in concierge models | Grown from ~25% to more than 40% of workforce in concierge practices |
| Traditional PCP daily patient volume | 20–25 patients per day |
| Concierge physician daily patient volume | 6–10 patients per day |
| Concierge physician appointment length | 30–60 minutes or more per visit |
| Traditional primary care appointment length | 15–20 minutes per visit |
| MDVIP affiliated physicians (as of 2024) | Over 1,300 affiliated physicians |
| MDVIP patient retention rate | 90% patient retention |
| MDVIP physician satisfaction | 96% physician satisfaction rate |
| Physician burnout relief via concierge model | 72% of surveyed physicians agree the model has potential to reduce burnout |
| Employer concierge coverage | ~5 million employees covered through employer concierge benefit programs |
| Top health systems offering concierge medicine | Cleveland Clinic, Johns Hopkins, Northwestern Medicine, Mass General, Rush University |
Source: Becker’s Hospital Review October 2025; Concierge Medicine Today January 2026; MDVIP December 2024; Mordor Intelligence January 2026; Sermo Physician Survey 2025; Grand View Research US Concierge Medicine Report 2024
The physician-level statistics for concierge medicine in 2026 reveal why this model has grown by 83% in just five years, and why that growth is accelerating rather than plateauing. The core value proposition is remarkably simple: a concierge physician sees 6 to 10 patients per day instead of 25, with each visit lasting 30 to 60 minutes instead of 15. That structural difference translates directly into clinical quality — the physician has time to think, to probe beyond the presenting complaint, to remember the patient’s family situation, to monitor trends across visits, and to catch things that the 15-minute rush model routinely misses. The 96% physician satisfaction rate at MDVIP — a network of over 1,300 affiliated doctors — is one of the strongest satisfaction figures anywhere in American professional life, let alone in the notoriously burnout-prone field of primary care medicine.
The NP/PA workforce growing from 25% to over 40% of concierge practice staff mirrors national healthcare workforce trends and signals that concierge practices are evolving into team-based care models rather than solo-physician boutiques. This structural evolution is important because it addresses one of the most common criticisms of concierge medicine: that it removes physicians from the broader system and worsens physician shortages. The data from Concierge Medicine Today suggests that many physicians entering concierge models were already planning to retire or leave medicine entirely — meaning the transition preserves their clinical contribution rather than extracting it from the system. The employer-sponsored adoption covering approximately 5 million employees is perhaps the clearest sign that concierge medicine is leaving its image as a wealthy individual’s indulgence behind, entering the corporate benefits mainstream where its preventive care model can demonstrate measurable value.
Concierge Medicine Membership Fees & Market Segments in the US 2026
| Fee / Segment Metric | Statistic |
|---|---|
| Annual membership fee range (median) | $2,000–$5,000 per year |
| Full annual fee range | $1,500 to $30,000 per year depending on tier |
| VIP/luxury tier fees | Above $10,000 per year (growing at 10.16% CAGR) |
| Ultra-premium AI longevity plans | $8,000–$19,000 per year (e.g., Human Longevity Clinic, 2025) |
| Mid-level membership tier revenue share | 39.28% of market at $3,000–$10,000/year |
| Average fee in 2014 | $1,500–$1,700 per year |
| Average fee by 2025 | $2,000–$5,000 per year (median) |
| Primary care application share (2024) | 26.72% of US market; 38.6% globally (varies by study) |
| Cardiology application share (2025) | 27.31% of global concierge market |
| Pediatrics growth rate | Highest CAGR at 11.62% from 2026 to 2031 |
| Group ownership market share (2024–2025) | 59.83–64.2% of the global market |
| In-person care market share (2025) | 62.86% of market; dominant delivery mode |
| House-call repeat booking intent (2024) | 94.2% repeat-booking intent in 2024 review |
| Top 1% income earners using concierge (2020) | 22% of top US income earners engaged in concierge medicine |
Source: Mordor Intelligence Concierge Medicine Market January 2026; PartnerMD 2025; Grand View Research US Market 2024; Coherent Market Insights 2025; Becker’s Hospital Review October 2025; Precedence Research November 2025
Membership fee dynamics in concierge medicine in 2026 illustrate how the market has stratified into clearly defined tiers, each serving a distinct patient segment with different expectations and economic profiles. The median $2,000–$5,000 annual fee represents the core market — professionals and families seeking same-day access, extended consultations, and proactive preventive care beyond what insurance-based medicine delivers. At the top end, ultra-premium longevity-focused programs pricing at $8,000–$19,000 per year bundle genomic screening, AI-powered health analysis, 24/7 physician availability, house calls, and comprehensive executive health packages — a market that has grown sharply as North America’s high-net-worth cohort increased by 7.3% in 2024 and continues to age.
The cardiology segment commanding 27.31% of the 2025 market is a critical data point that often gets underreported in the standard concierge medicine narrative, which tends to focus heavily on primary care. Cardiovascular disease remains the leading cause of death in the US, and the appeal of a cardiology concierge model — where a specialist knows your baseline measurements, tracks your biomarkers proactively, and is reachable at 2 AM when chest tightness develops — is enormous for at-risk patients and their families. The 94.2% repeat-booking intent for house-call services documented in 2024 confirms what concierge physicians have long argued: once patients experience medicine delivered in this manner, returning to 15-minute assembly-line appointments is no longer acceptable. The model retains patients not through lock-in, but through a quality of care that is genuinely hard to replicate elsewhere.
Precision Diagnostics Statistics in the US 2026
| Precision Diagnostics / Medicine Metric | Statistic |
|---|---|
| Global precision medicine market (2026) | $138.67 billion |
| US precision medicine market (2025) | $58.09 billion |
| Global precision medicine CAGR (2026–2035) | 16.26% |
| US precision medicine projection (2035) | $265.69 billion |
| Global precision diagnostics & medicine (2025) | $145.53 billion (valued at $132.46 billion in 2024) |
| Precision diagnostics market CAGR | 18.4% from 2024 to 2030 |
| Precision diagnostics market (2026–2033 CAGR) | 11.21% |
| US precision medicine market projection to 2026 | $53.5 billion |
| North America precision medicine market share (2025) | ~54% of global market |
| Oncology — largest precision medicine segment | 31.93% of market share (2026) |
| Genetic tests — largest diagnostics segment | 54.6% of precision diagnostics revenue (2023) |
| Companion diagnostics on-label combinations | Over 150 combinations in active use |
| AI in precision medicine market (2024–2034 CAGR) | 25.54% CAGR; from $2.74 billion (2024) to $26.66 billion by 2034 |
| Diagnostics segment share of precision market | 47.49% of precision medicine market (2026) |
Source: Precedence Research Precision Medicine Market December 2025; MarketsandMarkets Precision Diagnostics & Medicine Market 2024; Grand View Research Precision Medicine & Diagnostics Market 2024; Fortune Business Insights Precision Medicine Market; Toward Healthcare Precision Diagnostics Report February 2026; AnalystView Market Insights April 2026
Precision diagnostics in 2026 represents the technological backbone that transforms the concierge medicine model from high-quality traditional primary care into something genuinely different in kind — a system where clinical decisions are informed by genomic profiles, biomarker panels, companion diagnostics, and AI-powered pattern recognition rather than age-adjusted averages and population-level guidelines. The $138.67 billion global precision medicine market in 2026 — growing at 16.26% annually through 2035 — is expanding faster than almost any other healthcare segment, reflecting both the rapid cost reduction of genomic sequencing and the growing body of clinical evidence that targeted, biomarker-driven interventions outperform one-size-fits-all approaches for oncology, cardiovascular disease, rare genetic disorders, and increasingly, neurological conditions.
The US commanding 54% of the global precision medicine market at $58.09 billion in 2025 is not surprising given America’s combination of world-leading biotech investment, the strongest genomic research infrastructure on earth, and a private-payer environment that creates economic incentives for novel high-value diagnostics. The oncology segment representing nearly 32% of the precision medicine market reflects where the evidence is deepest — cancer genomics has advanced to the point where treatment decisions routinely depend on tumor mutation profiling, and the over 150 companion diagnostic on-label combinations now in active clinical use represent years of FDA approvals that have made precision oncology standard of care rather than experimental. The AI-in-precision-medicine market growing at 25.54% CAGR to reach $26.66 billion by 2034 signals the next frontier: not just identifying the right treatment, but predicting patient responses in real time.
Concierge Medicine & Precision Diagnostics: Combined Value in 2026
| Combined Value Metric | Detail |
|---|---|
| Sollis Health + Prenuvo partnership (2024) | Whole-body MRI for early detection of cancer, aneurysms, other conditions — offered to concierge members |
| Tempus AI — “Olivia” health concierge app (2025) | AI-powered personal health concierge integrating precision medicine data for patients |
| Forward Health AI diagnostics funding (2024) | $100 million Series D to roll out AI-empowered virtual clinics and remote diagnostic tools |
| Human Longevity Clinic — AI longevity plans | Ultra-premium AI-integrated longevity plans at $8,000–$19,000/year |
| AI-matched cancer drug tool (NIH, 2024) | NIH researchers developed AI-based tool to match cancer drugs with patients based on tumor genetic profiles |
| 65% of employees prefer personalized benefit options | Including personalized healthcare — Aon 2025 Global Benefits Trends Study |
| Telehealth adoption rise | From 43% of physicians pre-pandemic to 88% post-pandemic |
| Pharmacogenomics in concierge diagnostics | Tests predict what medications and doses will be effective and safe based on individual genetics |
| AlloMap genomic test | Detects whether immune system is rejecting a heart transplant — replaces invasive biopsy |
| Breast cancer recurrence reduction via targeted therapy | Targeted drugs like trastuzumab reduce recurrence by up to 52% in eligible patients |
| Heart transplant rejection rate | Approximately 25% of transplant patients experience rejection — precision diagnostics help manage this |
Source: Coherent Market Insights 2025; Precedence Research November 2025; MarketsandMarkets Precision Diagnostics 2024; Aon 2025 Global Benefits Trends Study via JMCO; media.market.us Precision Medicine Statistics 2026
The intersection of concierge medicine and precision diagnostics in 2026 is where the most exciting — and highest-value — developments in American healthcare are occurring. The Sollis Health and Prenuvo partnership launched in April 2024 is a perfect case study: a concierge medicine provider pairing with a whole-body MRI company to offer radiation-free, comprehensive early-detection imaging to its members. This is the kind of proactive, prevention-focused clinical offering that traditional insurance-based medicine has never been structured to deliver at scale. Detecting cancer, aneurysms, and critical conditions before symptoms appear is exactly what concierge medicine’s longer appointment times, ongoing physician relationships, and elevated diagnostic budgets make possible.
The Tempus AI “Olivia” app launched in January 2025 — an AI-powered personal health concierge that integrates precision medicine data — represents the software layer being built on top of the human relationship model that concierge medicine has always offered. When a physician has only 400 patients instead of 2,000, they have the cognitive bandwidth to actually use precision diagnostic outputs: genomic risk panels, pharmacogenomics results that predict drug responses, biomarker trends over time, and AI-generated flags for early disease signals. The 65% of employees who prefer personalized benefit options according to Aon’s 2025 Global Benefits Trends Study — and the 88% of physicians using telehealth post-pandemic — confirm that both patient demand and physician capability are converging on a model where medicine is genuinely tailored to the individual. In 2026, concierge medicine is the delivery vehicle; precision diagnostics is the fuel.
Key Challenges & Policy Developments in Concierge Medicine in the US 2026
| Challenge / Policy | Detail | Status / Year |
|---|---|---|
| Cost barrier for access | Annual fees of $1,500–$30,000 out-of-pocket limit access to middle/lower-income populations | Major ongoing equity concern |
| Medicare / insurance exclusion | Membership fees generally not reimbursable under Medicare or commercial insurance | CMS guidance; ongoing regulatory limitation |
| One Big Beautiful Bill Act (2025) | Signed into law in July; allows health savings accounts (HSAs) to pay for concierge/DPC membership fees | Enacted July 2025 |
| HSA eligibility expansion | Allows patients to use HSAs for concierge/DPC membership fees — improves affordability | Policy milestone 2025 |
| Medicaid recipients and DPC access | New provisions passed allowing Medicaid recipients to access DPC services more easily | Recent legislative change |
| Stark Law compliance | Practices must comply with Stark Law (anti-self-referral) and Anti-Kickback Statute for Medicare patients | Ongoing regulatory requirement |
| Independent physician decline | Independent physicians now represent just 22% of all practices (down sharply) | Physicians Advocacy Institute Report 2022–24 |
| Physician-owned practice rate (2024) | Only 42.2% of doctors remain in physician-owned settings | Mordor Intelligence, citing 2024 data |
| JAMA Health Forum finding | Hospital-employed physicians charge 10.7% more than independent physicians | JAMA Health Forum, cited in Mordor Intelligence 2026 |
| CMS telehealth extensions through 2026 | CMS rules continue to reimburse telehealth across geographic locations through 2026 | CMS rule, effective through 2026 |
| Equity concern — 60% skew risk | 60% of Sermo-surveyed physicians worry high-cost concierge model may skew doctor-patient relationships | Sermo Physician Survey 2025 |
| Systematic review evidence (2025) | Significantly increased patient and physician satisfaction confirmed; formal clinical outcome data still limited | American Journal of Medicine, March 2025 (49 studies reviewed) |
Source: Becker’s Hospital Review October 2025; Mordor Intelligence January 2026; American Journal of Medicine Systematic Review March 2025; Sermo Physician Survey 2025; CMS telehealth rules 2025–2026; Physicians Advocacy Institute 2022–24
Concierge medicine’s policy environment in 2026 has shifted meaningfully in favor of broader access, while the fundamental equity tension remains unresolved. The most consequential development is the passage of the One Big Beautiful Bill Act in July 2025, which explicitly allows individuals with high-deductible health plans to use their Health Savings Accounts to pay for concierge and Direct Primary Care membership fees. This is a structural affordability improvement that could meaningfully expand the viable market beyond the top income tiers — particularly as employer-sponsored HSA contributions become a vehicle for extending access to the model.
The systematic review of 49 studies published in the American Journal of Medicine in March 2025 provides the most rigorous available summary of the clinical evidence base, and its conclusions are nuanced but ultimately positive: significantly increased patient and physician satisfaction is confirmed by the literature, with the model demonstrating clear benefits in preventive care engagement, early illness identification, and reduced chronic disease progression. The honest caveat — that formal long-term clinical outcome data remains limited — reflects the field’s relative youth and the inherent difficulty of running controlled trials on a healthcare delivery model rather than a drug. What the data does confirm is that the patient and physician experience of concierge medicine is dramatically superior to traditional models, and that the economic case for preventive care over reactive treatment is strong enough that payers and employers are increasingly willing to fund it.
Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.